Brentuximab vedotin and anti‐PD1 treatment optimize survival in chemo‐refractory Hodgkin lymphoma patients: Real‐world data. Issue 4 (24th July 2019)

Record Type:: Journal Article
Title:: Brentuximab vedotin and anti‐PD1 treatment optimize survival in chemo‐refractory Hodgkin lymphoma patients: Real‐world data. Issue 4 (24th July 2019)
Main Title:: Brentuximab vedotin and anti‐PD1 treatment optimize survival in chemo‐refractory Hodgkin lymphoma patients: Real‐world data
Authors:: Sakellari, Ioanna
Gavriilaki, Eleni
Iskas, Michail
Bousiou, Zoi
Chatziioannidis, Aristotelis
Batsis, I.
Mallouri, Despina
Constantinous, Varnavas
Stavroyianni, Niki
Syrigou, Antonia
Marvaki, Anastasia
Pilavaki, Maria
Papaemmanouel, Styliani
Anagnostopoulos, Achilles
Abstract:
Is Part Of:: Hematological oncology. Volume 37:Issue 4(2019)
Journal:: Hematological oncology
Issue:: Volume 37:Issue 4(2019)
Issue Display:: Volume 37, Issue 4 (2019)
Year:: 2019
Volume:: 37
Issue:: 4
Issue Sort Value:: 2019-0037-0004-0000
Page Start:: 490
Page End:: 492
Publication Date:: 2019-07-24
Subjects:: Hematological oncology -- Periodicals
Hematology
Medical Oncology
616.99418005
Journal URLs:: http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1002/hon.2645 ↗
Languages:: English
ISSNs:: 0278-0232
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 4291.550000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 22873.xml